VBC signs collaboration agreement with LidoChem and Rizobacter to strengthen its biorational business
Apr. 27, 2016
- Sumitomo Chemical strengthens R&D activities to meet growing market demand
- Valent BioSciences to construct a new biorational research center
- Sumitomo Chemical to Strengthen R&D Capabilities for its Health & Crop Sciences Business in North America
- Valent BioSciences Corporation and Rizobacter signed R&D Cooperation Agreement for Biorationals
VBC has been waging an energetic drive recently to expand its biorational business in the U.S., opening a fermentation manufacturing facility in 2014 and acquiring Mycorrhizal Applications LLC, a producer of mycorrhizal fungal inoculum, in 2015. Furthermore, it will be building a new research unit as Biorational Research Center in Illinois, U.S.A. In parallel, Sumitomo Chemical has also taken steps forward, reinforcing its global agriculture-related business by integrating its plant protection chemicals business and VBC’s biorational business that have been conducted separately. With the global business matrix structure now established, Sumitomo Chemical Group is accelerating research and development activities, aiming to provide unique and innovative solutions for agriculture.
The new technologies that become available under the above two agreements will provide Sumitomo Chemical with a greater opportunity to satisfy market needs more swiftly and properly by capitalizing on the two technological disciplines of health and crop science, i.e. plant protection chemicals and biorationals, which will contribute to meeting the world’s growing demand for a secured and stable supply of safer foods.
More from AgroNews
Subscribe to daily email alerts of AgroNews.